References
- Acquired Immune Deficiency Syndrome (AIDS). Precautions for clinical and laboratory staffs. Centers for Disease Control, U. S.A. MMWR 1985; 34: 681–695
- Holt H A, Bywater W J, Reeves D S. Effects of inactivating HTLV-III on laboratory tests. Lancet 1985; 2: 99
- Spire B, Dormont D, Barre-Sinuussi F, Montagnier L, Chermann J. Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet 1985; 1: 188–189
- Pohlod D J, Saravolatz L D, Somerville M M. Comparison of enzyme-multiplied immunoassay technique with fluorescens polarization immunoassay for determination of gentamicin and tobramycin levels in serum. J Clin Microbiol 1984; 20: 866–868
- Ebert S C, Jorgensen J H, Drutz D J, Clementi W A. Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods. J Clin Microbiol 1984; 20: 701–705
- Martin L S, McDougal J S, Loskoski S L. Disinfection and inactivation of ttte human T lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 1985; 152: 400–403
- Pickering L K, Gearhart P. Effect of time and concentration upon interaction between gentamicin, tobramycin, netilmicin, or amikacin and carbenicillin or ticarcillin. Antimicrob Agents Chemother 1979; 15: 592–596